Reports
Reports
The global oncology information system (OIS) market is growing strongly, fueled primarily by the rising global burden of cancer and the need for efficient data management in cancer treatment. Such systems streamline clinical workflows by integrating patient data, treatment planning, and progress tracking in radiology, medical, and surgical oncology departments. Increased focus on precision oncology and personalized medicine is also driving adoption.
Progress in AI-based analytics, cloud-based platforms, and interoperable architecture is changing the competitive landscape. Integration with electronic health records and imaging applications is becoming the norm. Companies are positioning themselves strategically through product development, multi-institutional collaborations, and geographic expansion to solidify positions.
North America leads the market, thanks to a robust healthcare IT infrastructure and high levels of awareness. The Asian-Pacific’s market is growing rapidly, driven by investments in health digitization and rise in prevalence of cancer.
Europe continues to commit to automation and models of combined care, driving system use. Firms like Elekta, Varian (Siemens Healthineers), RaySearch, and Cerner are using AI, automation, and partnerships with cancer centers to bring more value to the clinic. The business is also moving away from conventional software to cloud-based, analytics-driven models that support decision, outcome, and value models of cancer treatment across the globe.
Global oncology information systems (OIS) market is growing at a rapid rate. As such, hospitals and cancer treatment centers are pushed to adopt electronic systems that can streamline processes, combine patient data, and support decision-making. Shifting toward precision oncology and personalized treatment also underlines the necessity of the same, as the systems enable the doctor to tailor the treatment as per the profile of the patient.
There were around 20 new cancer diagnoses and almost 10 cancer-related deaths in the year 2022 alone, thereby increasing the burden on the healthcare system even more to deliver timely and effective oncology care. One of the most powerful drivers to this market is the convergence of artificial intelligence and machine learning technologies. OIS platforms can provide intensive treatment regimens across all oncology domains.
They provide a unified platform to monitor the progress of the patient, coordinate care across several teams, and facilitate data-driven planning of the treatment. These technologies enable real-time patient monitoring, predictive analytics, and computerized treatment planning, thereby enhancing clinical outcomes and relief of administrative burden.
Cloud-delivery models and imaging and laboratory system integration are also growing in demand, with increased flexibility and scalability offered to healthcare providers. As cancer therapy continues to advance, the need for smarter, more sophisticated information systems will clearly become much larger. These systems are not only making companies more efficient; they are transforming cancer care delivery globally.
| Attribute | Detail |
|---|---|
| Oncology Information System (OIS) Market Drivers |
|
Higher rates of cancer worldwide are among the key reasons behind the implementation of oncology information systems. About 20 million new cancer cases and 9.7 million cancer deaths took place in 2022 (Global Cancer Statistics). Healthcare systems have never been under so much stress to absorb more patients with higher numbers in addition to delivering maximum quality of care.
The complexity of oncologic management from chemotherapy to radiotherapy to immunotherapy to target drugs demands exact synchronization and concurrent monitoring, and old or paper systems are too weak to face the challenge.
OIS systems facilitate the handling of high volumes of patient information, monitoring of treatment cycle progress, and seamless coordination among multidisciplinary teams. This is essential in the provision of timely interventions and the prevention of medical errors.
For example, a major cancer center in India has deployed an OIS to meet its increasing volume of breast and cervical cancer patients. In the system, treatment schedules could be automated, imaging reports accessed in real time, and adverse events monitored more efficiently, resulting in a 30% increase in treatment compliance and patient satisfaction. These benefits reinforce the need for scalable, digital solutions in the care of cancer as the burden of cancer worldwide continues to increase.
The transformation of cancer therapy to one that is more targeted and even personalized, i.e. precision oncology, is driving the need for more advanced information systems that accommodate molecular profiling, genomic data integration, and real-time decision support. Oncology information systems are becoming necessary tools for navigating this complexity, providing structured environments that can accommodate AI-based analytics and treatment personalization recommendations.
Precision oncology is based on the use of patient-specific information, and the information must be gathered, stored, processed, and examined in a way to transform it into useful information. These processes, made possible by OIS systems, allow oncologists to make predictions about outcomes and select treatments with higher success rates. It greatly improves the care quality and comprises the general direction of value-based care at its core.
For example, a cancer treatment center in Germany has included an AI-based OIS to tailor treatment protocols for its patients with non-small cell lung cancer. The system examined the clinical history of the patients, genomic markers, and treatment response to prescribe best-in-class medication combinations. This resulted in quicker initiation of treatment and improved clinical outcomes, which could be measured.
The software segment dominates the solution category due to its critical role in streamlining oncology care management. OIS software facilitates healthcare providers to efficiently manage patient records, treatment plans, clinical workflows, and scheduling-improving precision and consistency across oncology departments.
As cancer treatment becomes more complex, the requirement for integrated software solutions that support multidisciplinary approaches has grown significantly. The dominance of software is also driven by technological advancements such as cloud-based platforms, AI integration, and data analytics. These tools help oncologists in decision-making, outcome tracking, and personalized treatment planning.
For instance, Elekta’s OIS software “MOSAIQ” provides a unified platform for managing medical oncology, radiation therapy, and patient data in real time. It improves coordination between departments and enhances patient care by centralizing clinical information.
Moreover, software solutions offer scalability and remote access, which are increasingly valuable in both - large hospital networks and smaller cancer centers. With growing investments in digital health and electronic health record (EHR) systems, software continues to be the preferred solution in the OIS market.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America is likely to dominate the global oncology information system (OIS) market in forecast period. There is a strong ecosystem of oncology treatment facilities, academic medical centers, and suitable frameworks available in this region to enable adoption of digital health technologies.
Widespread early adoption of electronic health systems and digital platforms by oncology is one of the key drivers of this superiority. There is an extensive use of OIS solutions in U.S. cancer centers to facilitate standardized care, minimize errors, and provide improved outcomes. In addition to this, supportive reimbursement policies and robust support of the precision medicine programs by the government also fuel the acceptance of the technology.
For example, a number of U.S.-based National Cancer Institute (NCI)-designated cancer centers have implemented AI-driven OIS platforms to upgrade treatment planning and patient surveillance. They provide interoperability between diagnostic imaging, lab systems, and genomics data-presenting a consolidated view of the care of a patient.
Further, top players in the market, including Varian (Siemens Healthineers), Elekta, and Cerner, are based in or have firm operational bases in North America, accelerating innovation cycles and timely product releases. Consequently, the region remains a benchmark in the area of clinical efficiency and transformation in oncology care.
Key players operating in the oncology information system (OIS) industry are investing through innovation, technological advancements, and strategic partnerships. They focus on enhancing imaging clarity, and expanding product portfolios, ensuring sustained growth and leadership in the evolving healthcare landscape.
Varian Medical Systems, Elekta, Philips Healthcare, Cerner, Epic Systems Corporation, McKesson, Flatiron Health, Siemens Healthineers, ViewRay, Inc., Accuray Incorporated, BrainLab, Oracle (Cerner Corporation,) RaySearch Laboratories, and others
Each of these players has been profiled in the oncology information system (OIS) market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2024 | US$ 3.3 Bn |
| Forecast Value in 2035 | US$ 7.1 Bn |
| CAGR | 7.2% |
| Forecast Period | 2025-2035 |
| Historical Data Available for | 2020-2024 |
| Quantitative Units | US$ Bn |
| Oncology Information System (OIS) Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The oncology information system (OIS) market was valued at US$ 3.3 Bn in 2024.
The oncology information system (OIS) market is projected to cross US$ 7.1 Bn by the end of 2035.
Rising global cancer burden and shift toward precision oncology and AI-driven treatment.
The CAGR is anticipated to be 7.2% from 2025 to 2035.
North America is expected to account for the largest share from 2025 to 2035.
Varian Medical Systems, Elekta, Philips Healthcare, Cerner, Epic Systems Corporation, McKesson, Flatiron Health, Siemens Healthineers, ViewRay, Inc., Accuray Incorporated, BrainLab, Oracle (Cerner Corporation,) RaySearch Laboratories, and others.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Oncology Information System (OIS) Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Oncology Information System (OIS) Market Analysis and Forecast, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Technology Analysis
5.2. Pricing Analysis
5.3. PESTEL Analysis
5.4. Regulatory Scenario by Region/Country
5.5. PORTER's Five Forces Analysis
5.6. Key Industry Events
5.7. Unmet Needs of the Market
5.8. Key Purchase Metrics for End-users
6. Global Oncology Information System (OIS) Market Analysis and Forecast, by Solution
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Solution, 2020-2035
6.3.1. Software
6.3.1.1. Patient Information Systems
6.3.1.1.1. Electronic Medical Records
6.3.1.1.2. Laboratory Information Systems
6.3.1.1.3. Radiology Information Systems
6.3.1.1.4. Others
6.3.1.2. Treatment Planning Systems
6.3.1.2.1. Clinical Decision Support Systems
6.3.1.2.2. Brachytherapy Treatment Planning Systems
6.3.1.2.3. Others
6.3.2. Services
6.4. Market Attractiveness Analysis, by Solution
7. Global Oncology Information System (OIS) Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2035
7.3.1. Medical Oncology
7.3.2. Radiation Oncology
7.3.3. Surgical Oncology
7.4. Market Attractiveness Analysis, by Application
8. Global Oncology Information System (OIS) Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2035
8.3.1. Hospitals & Ambulatory Surgical Centers
8.3.2. Diagnostic & Imaging Centers
8.3.3. Ablation & Cancer Care Centers
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Oncology Information System (OIS) Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2035
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Oncology Information System (OIS) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Solution, 2020-2035
10.2.1. Software
10.2.1.1. Patient Information Systems
10.2.1.1.1. Electronic Medical Records
10.2.1.1.2. Laboratory Information Systems
10.2.1.1.3. Radiology Information Systems
10.2.1.1.4. Others
10.2.1.2. Treatment Planning Systems
10.2.1.2.1. Clinical Decision Support Systems
10.2.1.2.2. Brachytherapy Treatment Planning Systems
10.2.1.2.3. Others
10.2.2. Services
10.3. Market Value Forecast, by Application, 2020-2035
10.3.1. Medical Oncology
10.3.2. Radiation Oncology
10.3.3. Surgical Oncology
10.4. Market Value Forecast, by End-user, 2020-2035
10.4.1. Hospitals & Ambulatory Surgical Centers
10.4.2. Diagnostic & Imaging Centers
10.4.3. Ablation & Cancer Care Centers
10.4.4. Others
10.5. Market Value Forecast, by Country, 2020-2035
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Solution
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Oncology Information System (OIS) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Solution, 2020-2035
11.2.1. Software
11.2.1.1. Patient Information Systems
11.2.1.1.1. Electronic Medical Records
11.2.1.1.2. Laboratory Information Systems
11.2.1.1.3. Radiology Information Systems
11.2.1.1.4. Others
11.2.1.2. Treatment Planning Systems
11.2.1.2.1. Clinical Decision Support Systems
11.2.1.2.2. Brachytherapy Treatment Planning Systems
11.2.1.2.3. Others
11.2.2. Services
11.3. Market Value Forecast, by Application, 2020-2035
11.3.1. Medical Oncology
11.3.2. Radiation Oncology
11.3.3. Surgical Oncology
11.4. Market Value Forecast, by End-user, 2020-2035
11.4.1. Hospitals & Ambulatory Surgical Centers
11.4.2. Diagnostic & Imaging Centers
11.4.3. Ablation & Cancer Care Centers
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2020-2035
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Solution
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Oncology Information System (OIS) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Solution, 2020-2035
12.2.1. Software
12.2.1.1. Patient Information Systems
12.2.1.1.1. Electronic Medical Records
12.2.1.1.2. Laboratory Information Systems
12.2.1.1.3. Radiology Information Systems
12.2.1.1.4. Others
12.2.1.2. Treatment Planning Systems
12.2.1.2.1. Clinical Decision Support Systems
12.2.1.2.2. Brachytherapy Treatment Planning Systems
12.2.1.2.3. Others
12.2.2. Services
12.3. Market Value Forecast, by Application, 2020-2035
12.3.1. Medical Oncology
12.3.2. Radiation Oncology
12.3.3. Surgical Oncology
12.4. Market Value Forecast, by End-user, 2020-2035
12.4.1. Hospitals & Ambulatory Surgical Centers
12.4.2. Diagnostic & Imaging Centers
12.4.3. Ablation & Cancer Care Centers
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020-2035
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Solution
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Oncology Information System (OIS) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Solution, 2020-2035
13.2.1. Software
13.2.1.1. Patient Information Systems
13.2.1.1.1. Electronic Medical Records
13.2.1.1.2. Laboratory Information Systems
13.2.1.1.3. Radiology Information Systems
13.2.1.1.4. Others
13.2.1.2. Treatment Planning Systems
13.2.1.2.1. Clinical Decision Support Systems
13.2.1.2.2. Brachytherapy Treatment Planning Systems
13.2.1.2.3. Others
13.2.2. Services
13.3. Market Value Forecast, by Application, 2020-2035
13.3.1. Medical Oncology
13.3.2. Radiation Oncology
13.3.3. Surgical Oncology
13.4. Market Value Forecast, by End-user, 2020-2035
13.4.1. Hospitals & Ambulatory Surgical Centers
13.4.2. Diagnostic & Imaging Centers
13.4.3. Ablation & Cancer Care Centers
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2020-2035
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Solution
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Oncology Information System (OIS) Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Solution, 2020-2035
14.2.1. Software
14.2.1.1. Patient Information Systems
14.2.1.1.1. Electronic Medical Records
14.2.1.1.2. Laboratory Information Systems
14.2.1.1.3. Radiology Information Systems
14.2.1.1.4. Others
14.2.1.2. Treatment Planning Systems
14.2.1.2.1. Clinical Decision Support Systems
14.2.1.2.2. Brachytherapy Treatment Planning Systems
14.2.1.2.3. Others
14.2.2. Services
14.3. Market Value Forecast, by Application, 2020-2035
14.3.1. Medical Oncology
14.3.2. Radiation Oncology
14.3.3. Surgical Oncology
14.4. Market Value Forecast, by End-user, 2020-2035
14.4.1. Hospitals & Ambulatory Surgical Centers
14.4.2. Diagnostic & Imaging Centers
14.4.3. Ablation & Cancer Care Centers
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2020-2035
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Solution
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis, by Company (2024)
15.3. Company Profiles
15.3.1. Varian Medical Systems
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. Elekta
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Philips Healthcare
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Cerner
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Epic Systems Corporation
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. McKesson
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Flatiron Health
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Siemens Healthineers
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
15.3.9. ViewRay, Inc.
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Business Strategies
15.3.9.5. Recent Developments
15.3.10. Accuray Incorporated
15.3.10.1. Company Overview
15.3.10.2. Financial Overview
15.3.10.3. Product Portfolio
15.3.10.4. Business Strategies
15.3.10.5. Recent Developments
15.3.11. BrainLab
15.3.11.1. Company Overview
15.3.11.2. Financial Overview
15.3.11.3. Product Portfolio
15.3.11.4. Business Strategies
15.3.11.5. Recent Developments
15.3.12. Oracle (Cerner Corporation)
15.3.12.1. Company Overview
15.3.12.2. Financial Overview
15.3.12.3. Product Portfolio
15.3.12.4. Business Strategies
15.3.12.5. Recent Developments
15.3.13. RaySearch Laboratories
15.3.13.1. Company Overview
15.3.13.2. Financial Overview
15.3.13.3. Product Portfolio
15.3.13.4. Business Strategies
15.3.13.5. Recent Developments
List of Tables
Table 01: Global Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Solution, 2020-2035
Table 02: Global Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Software, 2020-2035
Table 03: Global Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Patient Information Systems, 2020-2035
Table 04: Global Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Treatment Planning Systems, 2020-2035
Table 05: Global Oncology Information System (OIS) Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 06: Global Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by End-user, 2020-2035
Table 07: Global Oncology Information System (OIS) Market Value (US$ Bn) Forecast, By Region, 2020-2035
Table 08: North America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Country, 2020-2034
Table 09: North America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Solution, 2020-2035
Table 10: North America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Software, 2020-2035
Table 11: North America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Patient Information Systems, 2020-2035
Table 12: North America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Treatment Planning Systems, 2020-2035
Table 13: North America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 14: North America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by End-user, 2020-2035
Table 15: Europe Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 16: Europe Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Solution, 2020-2035
Table 17: Europe Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Software, 2020-2035
Table 18: Europe Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Patient Information Systems, 2020-2035
Table 19: Europe Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Treatment Planning Systems, 2020-2035
Table 20: Europe Oncology Information System (OIS) Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 21: Europe Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by End-user, 2020-2035
Table 22: Asia Pacific Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 23: Asia Pacific Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Solution, 2020-2035
Table 24: Asia Pacific Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Software, 2020-2035
Table 25: Asia Pacific Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Patient Information Systems, 2020-2035
Table 26: Asia Pacific Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Treatment Planning Systems, 2020-2035
Table 27: Asia Pacific Oncology Information System (OIS) Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 28: Asia Pacific Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by End-user, 2020-2035
Table 29: Latin America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 30: Latin America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Solution, 2020-2035
Table 31: Latin America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Software, 2020-2035
Table 32: Latin America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Patient Information Systems, 2020-2035
Table 33: Latin America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Treatment Planning Systems, 2020-2035
Table 34: Latin America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 35: Latin America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by End-user, 2020-2035
Table 36: Middle East and Africa Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 37: Middle East and Africa Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Solution, 2020-2035
Table 38: Middle East and Africa Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Software, 2020-2035
Table 39: Middle East and Africa Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Patient Information Systems, 2020-2035
Table 40: Middle East and Africa Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by Treatment Planning Systems, 2020-2035
Table 41: Middle East and Africa Oncology Information System (OIS) Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 42: Middle East and Africa Oncology Information System (OIS) Market Value (US$ Bn) Forecast, by End-user, 2020-2035
List of Figures
Figure 01: Global Oncology Information System (OIS) Market Value Share Analysis, by Solution, 2024 and 2035
Figure 02: Global Oncology Information System (OIS) Market Attractiveness Analysis, by Solution, 2025-2035
Figure 03: Global Oncology Information System (OIS) Market Revenue (US$ Bn), by Software, 2020-2035
Figure 04: Global Oncology Information System (OIS) Market Revenue (US$ Bn), by Services, 2020-2035
Figure 05: Global Oncology Information System (OIS) Market Value Share Analysis, by Application, 2024 and 2035
Figure 06: Global Oncology Information System (OIS) Market Attractiveness Analysis, by Application, 2025-2035
Figure 07: Global Oncology Information System (OIS) Market Revenue (US$ Bn), by Medical Oncology, 2020-2035
Figure 08: Global Oncology Information System (OIS) Market Revenue (US$ Bn), by Radiation Oncology, 2020-2035
Figure 09: Global Oncology Information System (OIS) Market Revenue (US$ Bn), by Surgical Oncology, 2020-2035
Figure 10: Global Oncology Information System (OIS) Market Value Share Analysis, by End-user, 2024 and 2035
Figure 11: Global Oncology Information System (OIS) Market Attractiveness Analysis, by End-user, 2025-2035
Figure 12: Global Oncology Information System (OIS) Market Revenue (US$ Bn), by Hospitals & Ambulatory Surgical Centers, 2020-2035
Figure 13: Global Oncology Information System (OIS) Market Revenue (US$ Bn), by Diagnostic & Imaging Centers, 2020-2035
Figure 14: Global Oncology Information System (OIS) Market Revenue (US$ Bn), by Ablation & Cancer Care Centers, 2020-2035
Figure 15: Global Oncology Information System (OIS) Market Revenue (US$ Bn), by Others, 2020-2035
Figure 16: Global Oncology Information System (OIS) Market Value Share Analysis, By Region, 2024 and 2035
Figure 17: Global Oncology Information System (OIS) Market Attractiveness Analysis, By Region, 2025-2035
Figure 18: North America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, 2020-2035
Figure 19: North America Oncology Information System (OIS) Market Value Share Analysis, by Country, 2024 and 2035
Figure 20: North America Oncology Information System (OIS) Market Attractiveness Analysis, by Country, 2025-2035
Figure 21: North America Oncology Information System (OIS) Market Value Share Analysis, by Solution, 2024 and 2035
Figure 22: North America Oncology Information System (OIS) Market Attractiveness Analysis, by Solution, 2025-2035
Figure 23: North America Oncology Information System (OIS) Market Value Share Analysis, by Application, 2024 and 2035
Figure 24: North America Oncology Information System (OIS) Market Attractiveness Analysis, by Application, 2025-2035
Figure 25: North America Oncology Information System (OIS) Market Value Share Analysis, by End-user, 2024 and 2035
Figure 26: North America Oncology Information System (OIS) Market Attractiveness Analysis, by End-user, 2025-2035
Figure 27: Europe Oncology Information System (OIS) Market Value (US$ Bn) Forecast, 2020-2035
Figure 28: Europe Oncology Information System (OIS) Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 29: Europe Oncology Information System (OIS) Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 30: Europe Oncology Information System (OIS) Market Value Share Analysis, by Solution, 2024 and 2035
Figure 31: Europe Oncology Information System (OIS) Market Attractiveness Analysis, by Solution, 2025-2035
Figure 32: Europe Oncology Information System (OIS) Market Value Share Analysis, By Application, 2024 and 2035
Figure 33: Europe Oncology Information System (OIS) Market Attractiveness Analysis, By Application, 2025-2035
Figure 34: Europe Oncology Information System (OIS) Market Value Share Analysis, by End-user, 2024 and 2035
Figure 35: Europe Oncology Information System (OIS) Market Attractiveness Analysis, by End-user, 2025-2035
Figure 36: Asia Pacific Oncology Information System (OIS) Market Value (US$ Bn) Forecast, 2020-2035
Figure 37: Asia Pacific Oncology Information System (OIS) Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 38: Asia Pacific Oncology Information System (OIS) Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 39: Asia Pacific Oncology Information System (OIS) Market Value Share Analysis, by Solution, 2024 and 2035
Figure 40: Asia Pacific Oncology Information System (OIS) Market Attractiveness Analysis, by Solution, 2025-2035
Figure 41: Asia Pacific Oncology Information System (OIS) Market Value Share Analysis, By Application, 2024 and 2035
Figure 42: Asia Pacific Oncology Information System (OIS) Market Attractiveness Analysis, By Application, 2025-2035
Figure 43: Asia Pacific Oncology Information System (OIS) Market Value Share Analysis, by End-user, 2024 and 2035
Figure 44: Asia Pacific Oncology Information System (OIS) Market Attractiveness Analysis, by End-user, 2025-2035
Figure 45: Latin America Oncology Information System (OIS) Market Value (US$ Bn) Forecast, 2020-2035
Figure 46: Latin America Oncology Information System (OIS) Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 47: Latin America Oncology Information System (OIS) Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 48: Latin America Oncology Information System (OIS) Market Value Share Analysis, by Solution, 2024 and 2035
Figure 49: Latin America Oncology Information System (OIS) Market Attractiveness Analysis, by Solution, 2025-2035
Figure 50: Latin America Oncology Information System (OIS) Market Value Share Analysis, By Application, 2024 and 2035
Figure 51: Latin America Oncology Information System (OIS) Market Attractiveness Analysis, By Application, 2025-2035
Figure 52: Latin America Oncology Information System (OIS) Market Value Share Analysis, by End-user, 2024 and 2035
Figure 53: Latin America Oncology Information System (OIS) Market Attractiveness Analysis, by End-user, 2025-2035
Figure 54: Middle East & Africa Oncology Information System (OIS) Market Value (US$ Bn) Forecast, 2020-2035
Figure 55: Middle East & Africa Oncology Information System (OIS) Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 56: Middle East & Africa Oncology Information System (OIS) Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 57: Middle East and Africa Oncology Information System (OIS) Market Value Share Analysis, by Solution, 2024 and 2035
Figure 58: Middle East and Africa Oncology Information System (OIS) Market Attractiveness Analysis, by Solution, 2025-2035
Figure 59: Middle East and Africa Oncology Information System (OIS) Market Value Share Analysis, by Application, 2024 and 2035
Figure 60: Middle East and Africa Oncology Information System (OIS) Market Attractiveness Analysis, By Application, 2025-2035
Figure 61: Middle East and Africa Oncology Information System (OIS) Market Value Share Analysis, by End-user, 2024 and 2035
Figure 62: Middle East and Africa Oncology Information System (OIS) Market Attractiveness Analysis, by End-user, 2025-2035
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Oncology Information System (OIS) Market